Genomenon, Inc

Genomic intelligence for clinical diagnostics and precision medicine development

Add To Watchlist
General Information
Company Name
Genomenon, Inc
Founded Year
2014
Location (Offices)
Ann Arbor, United States +1
Founders / Decision Makers
Mike Klein - CEO Megan S. Lim - Co-founder Steve Schwartz - CTO & Co-founder Candace Chapman - Vice President of Marketing Sean Kearney - Chief Financial Officer Mark J. Kiel - CSO & Co-founder
Number of Employees
151
Industries
Developer Tools, Enterprise Software
Funding Stage
Series Unknown
Social Media

Genomenon, Inc - Company Profile

Genomenon, Inc is a leading genomic intelligence company founded in 2014, with the mission to enhance patients’ lives by identifying the genomic drivers of genetic disease and cancer. Their slogan, "Genomic intelligence for clinical diagnostics and precision medicine development," encapsulates their focus. Combining AI with genomic expertise, Genomenon streamlines complex genetic data into actionable insights for patient diagnosis and precision medicine development. Their offerings span software, data, curation, and consulting services. The company's last $5.46M Venture Round investment on 16 May 2024 underscores investor confidence in its capabilities. Headquartered in the United States, Genomenon operates in the Developer Tools and Enterprise Software industries, positioning itself at the intersection of technology and healthcare.

Taxonomy: Genomics, Pharmaceuticals, Clinical Diagnostics, Software Tools, Genetic Diagnostics, Bioinformatics, Oncology, Next Generation Sequencing, DNA, Rare Diseases, Precision Medicine, Genomic Research

Funding Rounds & Investors of Genomenon, Inc (9)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round $5.46M - 16 May 2024
Series B $20.00M 10
IrishAngels, investor in Genomenon, Inc's Series B round Green Park & Golf Ventures, investor in Genomenon, Inc's Series B round Michigan Angel Fund, investor in Genomenon, Inc's Series B round Michigan Rise, investor in Genomenon, Inc's Series B round First Step Fund, investor in Genomenon, Inc's Series B round BroadOak Capital Partners, investor in Genomenon, Inc's Series B round Spring Mountain Capital, investor in Genomenon, Inc's Series B round Red Cedar Ventures, investor in Genomenon, Inc's Series B round Riverine Ventures, investor in Genomenon, Inc's Series B round University of Michigan, investor in Genomenon, Inc's Series B round
08 Mar 2022
Grant $1.70M 1 National Institutes of Health 15 Feb 2022
Series A $5.30M 9
IrishAngels, investor in Genomenon, Inc's Series A round Green Park & Golf Ventures, investor in Genomenon, Inc's Series A round Michigan Angel Fund, investor in Genomenon, Inc's Series A round Michigan Rise, investor in Genomenon, Inc's Series A round First Step Fund, investor in Genomenon, Inc's Series A round BroadOak Capital Partners, investor in Genomenon, Inc's Series A round Red Cedar Ventures, investor in Genomenon, Inc's Series A round InvestMichigan, investor in Genomenon, Inc's Series A round
Atain 		16 Mar 2021
Seed Round $2.48M 3
IrishAngels, investor in Genomenon, Inc's Seed Round round H.W. Kaufman Group, investor in Genomenon, Inc's Seed Round round
Mike Klein 		08 Jan 2019

View All 9 Funding Rounds

Latest News of Genomenon, Inc

View All

No recent news or press coverage available for Genomenon, Inc.

Similar Companies to Genomenon, Inc

View All
ACT Genomics - Similar company to Genomenon, Inc
ACT Genomics Make Personalized Medicine Accessible To All.
SeqOne - Similar company to Genomenon, Inc
SeqOne From Genome to Personalized Medicine
JMDNA - Similar company to Genomenon, Inc
JMDNA
DNA Link - Similar company to Genomenon, Inc
DNA Link 경험을 바탕으로 최고를 만듭니다.
Lidya Genomics - Similar company to Genomenon, Inc
Lidya Genomics Enhancing Genomic Diagnosis Using Advanced Machine Learning Solutions in English
Circle Decoration Circle Decoration

Want to dive deeper into Genomenon, Inc? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now